Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.69
0.03 (4.17%)
At close: Jun 16, 2025, 3:59 PM
0.69
-0.03%
After-hours: Jun 16, 2025, 07:49 PM EDT
4.17% (1D)
| Bid | 0.66 |
| Market Cap | 35.53M |
| Revenue (ttm) | 9.27M |
| Net Income (ttm) | -41.04M |
| EPS (ttm) | -0.65 |
| PE Ratio (ttm) | -1.06 |
| Forward PE | -0.86 |
| Analyst | Buy |
| Ask | 0.7 |
| Volume | 309,889 |
| Avg. Volume (20D) | 1,235,126 |
| Open | 0.66 |
| Previous Close | 0.66 |
| Day's Range | 0.65 - 0.69 |
| 52-Week Range | 0.62 - 1.70 |
| Beta | 0.02 |
Analyst Forecast
According to 0 analyst ratings, the average rating for XLO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-34.57%
Xilio Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
3 months ago
-6.2%
Xilio Therapeutics shares are trading lower. The company reported Q4 financial results.
